论文部分内容阅读
应用酶标单克隆与多克隆双抗体夹心法测定１４例支气管哮喘发作期病人血清可溶性白细胞介素２受体（ＳｏｌｕｂｌｅＩｎｔｅｒｌｅｕｋｉｎ２，ｓＩＬ－２Ｒ）水平，并同健康人、慢性支气管炎并发肺气肿病人和哮喘缓解期病人相比较；同时观察哮喘病人入院第四天ｓＩＬ－２Ｒ变化同ＦＥＶ１．０％变化的关系。结果表明，哮喘发作期ｓＩＬ－２Ｒ显著高于健康组（Ｐ＜０．０１）和哮喘缓解组及慢支肺气肿组（Ｐ＜０．０５），ｓＩＬ－２Ｒ变化同ＦＥＶ１．０％变化有显著相关性（ｒ＝－０．７６６，Ｐ＜０．０５）。提示活化的淋巴细胞同哮喘病发作密切相关。
Serum soluble interleukin 2 (Soluble Interleukin 2, sIL-2R) levels in 14 patients with bronchial asthma were measured by enzyme-linked monoclonal antibody and polyclonal antibody sandwich method. The results were compared with those of healthy people and chronic bronchitis patients with emphysema And asthma remission patients compared; the same time, patients with asthma on the fourth day of sIL-2R changes and FEV1.0% change in the relationship. The results showed that sIL-2R in asthma attack was significantly higher than that in healthy group (P <0.01) and asthma remission group and chronic bronchiole emphysema group (P <0.05) There was a significant correlation (r = -0.766, P <0.05). Tip activation of lymphocytes and asthma attacks are closely related.